about
Spiroindolones, a potent compound class for the treatment of malariaAssessment of the pharmacodynamic properties of antimalarial drugs in vivoProbing the multifactorial basis of Plasmodium falciparum quinine resistance: Evidence for a strain-specific contribution of the sodium-proton exchanger PfNHEIn vivo antimalarial activity of the beta-carboline alkaloid manzamine AAdaptive copy number evolution in malaria parasitesAsexual populations of the human malaria parasite, Plasmodium falciparum, use a two-step genomic strategy to acquire accurate, beneficial DNA amplificationsRandomized, placebo-controlled trial of atovaquone/proguanil for the prevention of Plasmodium falciparum or Plasmodium vivax malaria among migrants to Papua, Indonesia.High-throughput screening for potent and selective inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase.Randomized comparison of artemether-benflumetol and artesunate-mefloquine in treatment of multidrug-resistant falciparum malaria.The treatment of chloroquine-resistant malaria.Artemether-lumefantrine for the treatment of multidrug-resistant falciparum malaria.Current status of malaria and potential for control.Towards an understanding of the mechanism of pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: genotyping of dihydrofolate reductase and dihydropteroate synthase of Kenyan parasitesPotent and selective activity of a combination of thymidine and 1843U89, a folate-based thymidylate synthase inhibitor, against Plasmodium falciparum.Therapeutic responses to quinine and clindamycin in multidrug-resistant falciparum malariaTherapy with a combination of low doses of interleukin 12 and chloroquine completely cures blood-stage malaria, prevents severe anemia, and induces immunity to reinfection.KAF156 is an antimalarial clinical candidate with potential for use in prophylaxis, treatment, and prevention of disease transmission.Effects of mefloquine use on Plasmodium vivax multidrug resistanceTracking origins and spread of sulfadoxine-resistant Plasmodium falciparum dhps alleles in Thailand.Quinine plus clindamycin improves chemotherapy of severe malaria in children.4-aminoquinoline analogs of chloroquine with shortened side chains retain activity against chloroquine-resistant Plasmodium falciparumAntimalarial activity of the bisquinoline trans-N1,N2-bis (7-chloroquinolin-4-yl)cyclohexane-1,2-diamine: comparison of two stereoisomers and detailed evaluation of the S,S enantiomer, Ro 47-7737Naphthylisoquinoline alkaloids against malaria: evaluation of the curative potentials of dioncophylline C and dioncopeltine A against Plasmodium berghei in vivoSafety evaluation of the drugs available to prevent malaria.Antimalarial drug resistance and combination chemotherapy.Why is the Plasmodium falciparum hexose transporter a promising new drug target?Artesunate--amodiaquine combination therapy for falciparum malaria in young Gabonese children.Comparison of two mefloquine regimens for treatment of Plasmodium falciparum malaria on the northeastern Thai-Cambodian border.Variations in frequencies of drug resistance in Plasmodium falciparum.Essential protein-protein interactions between Plasmodium falciparum thymidylate synthase and dihydrofolate reductase domains.Genetic and genomic approaches for the discovery of parasite genes involved in antimalarial drug resistance.Recent advances in novel heterocyclic scaffolds for the treatment of drug-resistant malaria.Controlling malaria: challenges and solutions.Quinine in severe falciparum malaria: evidence of declining efficacy in Thailand.Efficacy and pharmacokinetics of atovaquone and proguanil in children with multidrug-resistant Plasmodium falciparum malaria.The pfmdr1 gene is associated with a multidrug-resistant phenotype in Plasmodium falciparum from the western border of Thailand.Analysis of antimalarial synergy between bestatin and endoprotease inhibitors using statistical response-surface modelling.Efficacy of proton pump inhibitor drugs against Plasmodium falciparum in vitro and their probable pharmacophores.In vitro activities of novel antifolate drug combinations against Plasmodium falciparum and human granulocyte CFUs.Plasmodium falciparum: Assessment of Selectivity of Action of Chloroquine, Alchornea cordifolia, Ficus polita, and Other Drugs by a Tetrazolium-Based Colorimetric Assay.
P2860
Q24606915-FC68BA96-8BA0-4099-B376-A0EBFA04E776Q24670346-B89D1B87-006E-4076-A83B-4B99E21EC107Q27861959-F32A6316-5E76-4BF9-9317-F9ADCA57D1EFQ28344290-9BD6161A-0353-449B-9BAE-416883065FDEQ28473933-F3B3C545-4F2A-4417-88D6-6307F8CC2F7DQ28533270-AC49C853-1BC7-4DA4-B07A-5FBAFC972C9BQ30847884-9C41A681-8AEE-4D08-AD86-DEB145EAC012Q31156888-00FC35AC-4188-4AD7-B2E3-2F07980C61AAQ33690621-A2107D5E-EBE6-4A78-9389-38C6638376A0Q33711587-8F697F0A-2336-44CE-BEFB-81D9C353E369Q33929311-4A83A16B-F74E-40B8-AE78-BC95441B13AEQ33975652-624D23C9-71D4-4E3D-9600-9228FEC37F67Q33979170-F53696ED-16A8-40DD-BFFC-67D43421D6D9Q33979229-604135C8-B61C-4E22-9562-15DF89FBEFFAQ33980472-F11C67C5-9767-40A3-AB7B-C48238FC85CCQ34000140-D58FD5F9-DF03-40A5-B7AD-E783FB87102BQ34057433-D2680093-DB89-4CBD-8CF4-3A9988FCEB69Q34320936-F5D6F14E-9044-4EAF-8DD1-5651ADB2A9ADQ34483523-38CD29CD-A695-4DEA-8090-A05459727F19Q35116473-25ADCD85-ECC4-401E-855E-C84AA416A12EQ35126083-393F119F-710E-45AE-BD4D-3275001662A6Q35134156-C62C4458-4598-4724-BC99-EE88D29D2959Q35139039-97BF4D9A-70EB-4AD8-BE67-CDD3ECAE6F9FQ35194527-A23DF695-C31F-4C69-A98E-5F2F04829694Q35212414-0E6E1633-3183-4F25-94C0-B2619CF08041Q35537890-17EADC07-86D6-4B29-80FF-CB632EDF8B13Q35695222-8CCBDD3C-A51E-4EAF-816B-D357996ABCD5Q35819658-2EA3A7B4-63B5-4D24-A05F-5FD55D6B998EQ36567189-D8BE4615-F187-45DC-B13C-F9B108EF6230Q37217964-F7E5BA5B-B10C-4853-8DAF-00E287A9D964Q38127840-9C43E237-48D7-4B1C-B113-D39E58740163Q38379720-AA063032-8E88-4E31-9A36-D75150F98576Q39322857-53E21D71-D7B4-4D17-A95D-B6263EC72F6AQ39370966-9BE1B042-4B06-4577-A62E-59E29FDDDA6BQ39417710-9DC9D249-E85B-4105-8C97-EF2331C1CCF2Q39472395-EAA4458E-B04C-4772-BFFC-3ED84FE1DFB6Q39478859-43E4C48C-7FC7-4E21-AE34-921B7D332BE8Q39652544-CF0EB7CF-6C8E-46AC-93AD-08987F54F8D1Q39779567-E6F3E0B9-2FCF-49ED-A8AC-019A11389EACQ40633071-33345CE0-2C92-4182-BFFD-E43BA3BAE424
P2860
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Antimalarial drug resistance: the pace quickens.
@ast
Antimalarial drug resistance: the pace quickens.
@en
type
label
Antimalarial drug resistance: the pace quickens.
@ast
Antimalarial drug resistance: the pace quickens.
@en
prefLabel
Antimalarial drug resistance: the pace quickens.
@ast
Antimalarial drug resistance: the pace quickens.
@en
P356
P1476
Antimalarial drug resistance: the pace quickens.
@en
P304
P356
10.1093/JAC/30.5.571
P407
P577
1992-11-01T00:00:00Z